{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:48:55Z","timestamp":1790376535273,"version":"4.1.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2012,5,1]],"date-time":"2012-05-01T00:00:00Z","timestamp":1335830400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,30]],"date-time":"2014-11-30T00:00:00Z","timestamp":1417305600000},"content-version":"vor","delay-in-days":943,"URL":"https:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clinical Microbiology and Infection"],"published-print":{"date-parts":[[2012,5]]},"DOI":"10.1111\/j.1469-0691.2011.03650.x","type":"journal-article","created":{"date-parts":[[2011,8,31]],"date-time":"2011-08-31T22:36:43Z","timestamp":1314830203000},"page":"449-458","source":"Crossref","is-referenced-by-count":64,"title":["Factors influencing the normalization of CD4+ T-cell count, percentage and CD4+\/CD8+ T-cell ratio in HIV-infected patients on long-term suppressive antiretroviral therapy"],"prefix":"10.1016","volume":"18","author":[{"given":"C.","family":"Torti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Prosperi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Motta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Digiambenedetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F.","family":"Maggiolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Paraninfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Ripamonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.","family":"Cologni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Fabbiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.L.","family":"Caputo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.","family":"Sighinolfi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Ladisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"El-Hamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Quiros-Roldan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I.","family":"Frank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1111\/j.1469-0691.2011.03650.x_bib1","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nm0795-674","article-title":"Failure of T\u2010cell homeostasis preceding AIDS in HIV\u20101 infection. The multicenter AIDS cohort study","volume":"1","author":"Margolick","year":"1995","journal-title":"Nat Med"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib2","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S1473-3099(06)70463-7","article-title":"Immunological recovery and antiretroviral therapy in HIV\u20101 infection","volume":"6","author":"Battegay","year":"2006","journal-title":"Lancet Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib3","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1001\/archinte.163.18.2187","article-title":"CD4 T\u2010lymphocyte recovery in individuals with advanced HIV\u20101 infection receiving potent antiretroviral therapy for 4\u2003years: the Swiss HIV cohort study","volume":"163","author":"Kaufmann","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib4","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1097\/QAI.0b013e318134257a","article-title":"HIV\u2010infected adults with a CD4 cell count greater than 500\u2003cells\/mm3 on long\u2010term combination antiretroviral therapy reach same mortality rates as the general population","volume":"46","author":"Lewden","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(07)60948-9","article-title":"Normalization of CD4 counts in patients with HIV\u20101 infection and maximum virological suppression who are taking combination antiretroviral therapy: an observational cohort study","volume":"370","author":"Mocroft","year":"2007","journal-title":"Lancet"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1086\/510746","article-title":"CD4+ cell count 6\u2003years after commencement of highly active antiretroviral therapy in persons with sustained virologic suppression","volume":"44","author":"Moore","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib7","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1089\/aid.2008.0149","article-title":"Evolution of CD4+ T\u2010cell count in HIV\u20101\u2010infected adults receiving antiretroviral therapy with sustained long\u2010term virological suppression","volume":"25","author":"Byakwaga","year":"2009","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib8","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/1471-2334-11-23","article-title":"Long\u2010term CD4+ T\u2010cell count evolution after switching from regimens including HIV nucleoside reverse transcriptase inhibitors (NRTI) plus protease inhibitors to regimens containing NRTI plus non\u2010NRTI or only NRTI","volume":"11","author":"Torti","year":"2011","journal-title":"BMC Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib9","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1086\/376638","article-title":"Do sex and race\/ethnicity influence CD4 cell response in patients who achieve virologic suppression during antiretroviral therapy?","volume":"37","author":"Giordano","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib10","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/QAI.0b013e31804d685b","article-title":"CD4 cell counts of 800\u2003cells\/mm3 or greater after 7\u2003years of highly active antiretroviral therapy are feasible in most patients starting with 350\u2003cells\/mm3 or greater","volume":"45","author":"Gras","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib11","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1097\/00126334-200406010-00007","article-title":"Long\u2010term CD4+ T\u2010cell response to highly active antiretroviral therapy according to baseline CD4+ T\u2010cell count","volume":"36","author":"Garc\u00eda","year":"2004","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib12","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1182\/blood-2003-09-3333","article-title":"Immune activation set point during early HIV infection predicts subsequent CD4+ T\u2010cell changes independent of viral load","volume":"104","author":"Deeks","year":"2004","journal-title":"Blood"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib13","doi-asserted-by":"crossref","first-page":"e203","DOI":"10.1371\/journal.pmed.0050203","article-title":"Inflammatory and coagulation biomarkers and mortality in patients with HIV infection","volume":"5","author":"Kuller","year":"2008","journal-title":"PLoS Med"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib14","doi-asserted-by":"crossref","first-page":"2409","DOI":"10.1097\/QAD.0b013e3283174636","article-title":"The role of HIV in serious diseases other than AIDS","volume":"22","author":"Phillips","year":"2008","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.3851\/IMP1513","article-title":"Predicting the magnitude of short\u2010term CD4+ T\u2010cell recovery in HIV\u2010infected patients during first\u2010line antiretroviral therapy","volume":"15","author":"Castagna","year":"2010","journal-title":"Antivir Ther"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib16","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1177\/135965350901400311","article-title":"CD4+ T\u2010cell percentage is an independent predictor of clinical progression in AIDS\u2010free antiretroviral\u2010naive patients with CD4+ T\u2010cell counts >200\u2003cells\/mm3","volume":"14","author":"Guiguet","year":"2009","journal-title":"Antivir Ther"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib17","doi-asserted-by":"crossref","first-page":"5737","DOI":"10.1182\/blood-2009-02-204172","article-title":"Hodgkin lymphoma in the Swiss HIV cohort study","volume":"113","author":"Clifford","year":"2009","journal-title":"Blood"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib18","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1111\/j.1365-2249.1991.tb05636.x","article-title":"Low CD4\/CD8 T lymphocyte ratio in acute myocardial infarction","volume":"83","author":"Syrj\u00e4l\u00e4","year":"1991","journal-title":"Clin Exp Immunol"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib19","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archinternmed.2010.197","article-title":"Impact of individual antiretroviral drugs on the risk of myocardial infarction in human immunodeficiency virus\u2010infected patients: a case\u2010control study nested within the French Hospital Database on HIV ANRS cohort CO4","volume":"170","author":"Lang","year":"2010","journal-title":"Arch Intern Med"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib20","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1214\/aos\/1176345976","article-title":"Cox\u2019s regression model for counting processes, a large sample study","volume":"10","author":"Andersen","year":"1982","journal-title":"Ann Stat"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib21","series-title":"Modeling survival data: extending the cox model","author":"Therneau","year":"2000"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib22","first-page":"1","article-title":"Guidelines for the use of antiretroviral agents in HIV\u20101\u2010infected adults and adolescents","author":"Panel on Antiretroviral Guidelines for Adults and Adolescents","year":"2011","journal-title":"Department of Health and Human Services"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib23","series-title":"The elements of statistical learning: data mining, inference, and prediction","author":"Hastie","year":"2009"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib24","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1146\/annurev.ps.46.020195.003021","article-title":"Multiple hypothesis testing","volume":"46","author":"Shaffer","year":"1995","journal-title":"Annual Rev Psychol"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib25","series-title":"R: A language and environment for statistical computing","author":"R Development Core Team","year":"2009"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib26","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1097\/00126334-200106010-00012","article-title":"Increase and plateau of CD4+ T\u2010cell counts in the 3(1\/2) years after initiation of potent antiretroviral therapy","volume":"27","author":"Tarwater","year":"2001","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib27","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1097\/00002030-200209270-00002","article-title":"Limited immune restoration after 3\u2003years\u2019 suppression of HIV\u20101 replication in patients with moderately advanced disease","volume":"16","author":"Valdez","year":"2002","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib28","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1097\/QAD.0b013e3282f88d02","article-title":"Response to combination antiretroviral therapy: variation by age","volume":"22","year":"2008","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib29","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00126334-200209010-00003","article-title":"Baseline predictors of CD4 T\u2010lymphocyte recovery with combination antiretroviral therapy","volume":"31","author":"Bennett","year":"2002","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib30","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/01.qai.0000226789.51992.3f","article-title":"Effect of baseline\u2010 and treatment\u2010related factors on immunologic recovery after initiation of antiretroviral therapy in HIV\u20101\u2010positive subjects: results from ACTG 384","volume":"42","author":"Gandhi","year":"2006","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1097\/QAI.0b013e31802c7e20","article-title":"Pretreatment factors associated with 3\u2010year (144\u2010week) virologic and immunologic responses to potent antiretroviral therapy","volume":"44","author":"Bosch","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib32","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1086\/342695","article-title":"Long\u2010term outcomes among antiretroviral\u2010naive human immunodeficiency virus\u2010infected patients with small increases in CD4+ cell counts after successful virologic suppression","volume":"35","author":"Dronda","year":"2002","journal-title":"Clin Infect Dis"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib33","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/00002030-200201250-00014","article-title":"Different degree of immune recovery using antiretroviral regimens with protease inhibitors or non nucleosides","volume":"16","author":"Barreiro","year":"2002","journal-title":"AIDS"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib34","doi-asserted-by":"crossref","first-page":"445","DOI":"10.7326\/0003-4819-154-7-201104050-00316","article-title":"Atazanavir plus ritonavir or efavirenz as part of a 3\u2010drug regimen for initial treatment of HIV\u20101","volume":"154","author":"Daar","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib35","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1097\/QAI.0b013e3181cae4a1","article-title":"Prospective, randomized, open label trial of Efavirenz vs Lopinavir\/Ritonavir in HIV+ treatment\u2010naive subjects with CD4+<200\u2003cell\/mm3 in Mexico","volume":"53","author":"Sierra\u2010Madero","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib36","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.antiviral.2009.11.008","article-title":"Similar antiviral efficacy and tolerability between efavirenz and lopinavir\/ritonavir, administered with abacavir\/lamivudine (Kivexa), in antiretroviral\u2010na\u00efve patients: a 48\u2010week, multicentre, randomized study (Lake Study)","volume":"85","author":"Echeverr\u00eda","year":"2010","journal-title":"Antiviral Res"},{"key":"10.1111\/j.1469-0691.2011.03650.x_bib37","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1086\/597093","article-title":"Incomplete peripheral CD4+ cell count restoration in HIV\u2010infected patients receiving long\u2010term antiretroviral treatment","volume":"48","author":"Kelley","year":"2009","journal-title":"Clin Infect Dis"}],"container-title":["Clinical Microbiology and Infection"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14625489?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1198743X14625489?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,6,9]],"date-time":"2023-06-09T03:06:38Z","timestamp":1686279998000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1198743X14625489"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2012,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2012,5]]}},"alternative-id":["S1198743X14625489"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-0691.2011.03650.x","relation":{},"ISSN":["1198-743X"],"issn-type":[{"value":"1198-743X","type":"print"}],"subject":[],"published":{"date-parts":[[2012,5]]}}}